Tremor
TrialsCompanies

Not investment advice.

Tremor shows what changed in public records. It never tells anyone to buy or sell. Many trial edits are harmless paperwork. Data from ClinicalTrials.gov, the SEC, and the Federal Register.

PrivacyTerms

BMYBristol-Myers SquibbSigning up patients

A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Solid Tumors

3Calmworry score, out of 100

No strong warning signs right now. The score counts warning signs; it is not a prediction.

Why this score

  • 2 insiders sold shares within a month

    Since Sep 9, 2026 · was worth 5, fading over time

    +2.6
Worry score3

Score over time

Stage
Phase 2
Patients
254 (planned)
Started
Jul 27, 2026
Main results expected
Aug 15, 2028
Fully finished
May 20, 2032
Results posted
not yet

What counts as success

The trial's main goal(s), called the “primary outcome.”

  • Part 1: Number of participants who achieve Objective Response (OR)

    Measured over: Up to approximately 2 years

  • Part 2: Number of participants with adverse events meeting protocol defined dose limiting toxicities (DLTs) criteria

    Measured over: Up to approximately 2 years

  • Part 2: Number of participants with adverse events (AE)

    Measured over: Up to approximately 2 years

  • Part 2: Number of participants with Serious AEs (SAEs)

    Measured over: Up to approximately 2 years

  • Part 2: Number of participants with treatment related AEs

    Measured over: Up to approximately 2 years

  • Part 2: Number of participants with treatment related SAEs

    Measured over: Up to approximately 2 years

  • Part 2: Number of participants with AEs leading to study treatment discontinuation

    Measured over: Up to approximately 2 years

  • Part 2: Number of participants with AEs leading to death

    Measured over: Up to approximately 2 years

  • Part 2: Number of participants with laboratory abnormalities

    Measured over: Up to approximately 2 years

Changes Tremor has spotted

No changes since Tremor started watching this trial.
Show details (technical version)

Score inputs

  • insider_selling_cluster: base 5, now 2.6, since 2026-09-09, fades (half-life)

Raw record changes

  • none yet

Trial ID NCT07492680 · record last updated 2026-11-04 · checked 2026-11-09 15:47 UTC

See the official record on ClinicalTrials.gov (NCT07492680) ↗